Loading ...Publications 
Antiviral Treatment for Patients Hospitalized with 2009 Pandemic Influenza A (H1N1)(2)
With the 2009 H1N1 pandemic well under way, many clinicians are providing care to patients with influenza. Previously, although antiviral treatment was recommended,1,2 clinicians may not always have prescribed it to patients hospitalized with seasonal influenza, perhaps because of a perception that antiviral treatment had limited benefit.
Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans
CORRESPONDENCE
Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans
C.C. Blyth, J.R. Iredell, and D.E. Dwyer
Rapid antigen tests, as compared with RT-PCR assays, had poor sensitivity to the 2009 influenza A (H1N1) virus in 21 patients with severe infection and acute lung injury that required mechanical ventilation.
Full Text | PDF
New H1N1 Vaccine Approved in U.S.
The FDA has approved a fifth vaccine for 2009 H1N1 influenza for use in adults. GlaxoSmithKline says it expects to begin shipments in December.
Rapid Influenza Test Helps Identify Low-Risk Febrile Infants
A positive rapid influenza test result predicted low risk for serious bacterial infection in febrile infants younger than 3 months. (more…)
More in this category
- ECMO for Patients with 2009 H1N1 Influenza and ARDS
- Estimates of Flu’s Toll; Seasonal Vaccine Not Effective Against 2009 H1N1
- Background Events and Mass Vaccination
- Prevention of Flu Transmission in Households
- Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
- Older Age and a Reduced Likelihood of 2009 H1N1 Virus Infection
